SumanPaulMD

Physician

Dr. Paul is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1800 Orleans Street
Baltimore, MD 21287
Phone+1 410-955-5000

Fax+1 410-955-5001

PubMed

Improved Overall Survival with Checkpoint Inhibition and Allogeneic Transplantation in Relapsed Hodgkin Lymphoma.
Nadeem Tabbara, Marianna L Zahurak, Cole Sterling, Iris Margalit Trutzer, Jaroslaw Jedrych
Blood Advances. 2024-12-18
Antibody-Based Therapies for Peripheral T-Cell Lymphoma.
Nazila Shafagati, Suman Paul, Sima Rozati, Cole H Sterling
Cancers. 2024-10-15
2 citations
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.
Brian J Mog, Nikita Marcou, Sarah R DiNapoli, Alexander H Pearlman, Tushar D Nichakawade
Science Translational Medicine. 2024-07-10

Lectures

Targeting MHC-linked wild type p53 with TCR mimic single chain diabody for cancer immunotherapy.
2019 ASCO Annual Meeting - 6/1/2019
Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Ludwig Johns Hopkins Researchers Devise New Strategy for Cancer ImmunotherapyMarch 2nd, 2021
Breakthrough in Controlling T Cell ActivationMay 13th, 2014
Investigators Develop Novel Treatment for T-cell Leukemias and LymphomasApril 3rd, 2024
Join now to see all